Over 40 genetic links to rheumatoid arthritis discovered
One of Canada’s pre-eminent researchers, Dr. Kathy Siminovitch, played a leading role in a study that identifies over 40 new genetic links to rheumatoid arthritis, published in Nature on December 25, 2103. The discovery opens the door to a personalized approach to treating the autoimmune disorder, allowing medications to target a person’s individual genetic make up.
Rheumatoid arthritis is a leading cause of disability world-wide, afflicting up to one in a hundred individuals, according to World Health Organization estimates. About half of adults with the autoimmune disease are unable to work full time within 10 years of diagnosis. The findings of this study by an international consortium of researchers, including Dr. Siminovitch, offer new potential targets for therapy. She is the Director of the Office of Personalized Genomics and Innovative Medicine at Mount Sinai Hospital and a Senior Investigator at the hospital’s Lunenfeld-Tanenbaum Research Institute in Toronto, Canada.
Entry filed under: Biotechnology News and Info from Canadian Universities. Tags: Canadian Research, Mount Sinai Hospital, University of Toronto.